key: cord-0819421-ymoay9nq
authors: Crimi, Claudia; Impellizzeri, Pietro; Campisi, Raffaele; Nolasco, Santi; Spanevello, Antonio; Crimi, Nunzio
title: Practical considerations for Spirometry during the COVID-19 outbreak: Literature Review and Insights
date: 2020-08-05
journal: Pulmonology
DOI: 10.1016/j.pulmoe.2020.07.011
sha: bd3b3aa2a41f60d1ac96f265b7ecf84b036f5d48
doc_id: 819421
cord_uid: ymoay9nq

BACKGROUND: As the Coronavirus disease 2019 (COVID-19) is spreading worldwide, countries are dealing with different phases of the pandemic. Lately, scientific evidence has been growing about the measures for reopening respiratory outpatient services during the COVID-19 pandemic. We aim to summarize the key differences and similarities among recommendations by different national and international organizations. METHODS: We searched on Google and Pubmed for recently published National and International Recommendations/Guidelines/Position Papers from professional organizations and societies, offering a guidance to physicians on how to safely perform pulmonary function testing during COVID-19 pandemic. We also searched for spirometry manufacturers' operational indications. RESULTS: Indications on spirometry were released by the Chinese Task force, the American Thoracic Society, the European Respiratory Society, the Thoracic Society of Australia and New Zealand, the Société de Pneumologie de Langue Française, the Spanish Societies (Sociedad Espanola de Neumologia y Cirugia Toracica, Sociedad Espanola de Alergologia e Inmunologia Clinica, Asociacion de Especialistas en Enfermeria del trabajo, Asociacion de Enfermeria Comunitaria), the Sociedade Portuguesa de Pneumologia, the British Thoracic Society/Association for Respiratory Technology & Physiology, the Irish Thoracic Society, the Sociedad Uruguaya de Neumologia, the Italian Thoracic Society and the Italian Respiratory Society, Cleveland Clinic and Nebraska Medical Center. Detailed technical recommendations were found on manufacturers’ websites. We found several similarities across available guidelines for safely resuming pulmonary function services, as well as differences in criteria for selecting eligible patients for which spirometry is deemed essential and advice which was not homogenous on room ventilation precautions. CONCLUSIONS: This study shows a synthesis of national/international guidelines allowing practicing physicians to adapt and shape the way to organize their outpatient services locally. There is generally good agreement on the importance of limiting pulmonary function testing to selected cases only. However, significant differences concerning the subsets of candidate patients, as well as on the management of adequate room ventilation, were observed.

Coronavirus disease 2019 (COVID-19) has spread worldwide, becoming a public health emergency of international concern 1 , officially designated as a pandemic by World Health Organization (WHO) on March 11 2 . COVID-19 has had a high impact on the health care system, necessitating unprecedented measures for containing the infection, shutting down all the outpatient activities and providing treatment only for emergency cases 3 .

The infection is mainly transmitted by respiratory droplets 4 and close contacts, so both pulmonologists and their patients are at high risk of COVID-19 transmission during the outpatient visit and the pulmonary function testing procedures.

Therefore, in the early phases of the pandemic some International Societies such as the Chinese expert consensus 5 , the American Thoracic Society (ATS) 6 , the Thoracic Society of Australia and New Zealand (TSANZ/ANZSRS) 7 , the Sociedade Portuguesa de Pneumologia (SPP) 8 11 , recommended stopping or postponing pulmonary visits and pulmonary function tests (PFTs) during the pandemic surge unless deemed clinically essential 5-8, 11, 12 .

Nevertheless, PFTs cannot be delayed for a long time in some patients' groups.

Moreover, a respiratory follow-up of patients who recovered from COVID-19 pneumonia is crucial in the monitoring of a possible fibrotic complication of the disease which could lead to a reduction of the pulmonary function 1, 5 .

Entering the second phase of the COVID-19 pandemic, we need to consider that the infection will remain endemic and we have to coexist with the disease, which will J o u r n a l P r e -p r o o f become a part of the routine practice. Therefore, hospitals have to be prepared to safely bring back regular ambulatory services and PFT labs, especially to assess patients suffering from pre-existing chronic respiratory diseases, to prevent their risk of mortality and disability.

To date, several official Recommendations/Guidelines from National and International Societies, hospitals or professional organizations have been released on this topic with operational indications during the COVID-19 surge [5] [6] [7] [8] [9] [10] [11] 13 . Some Organizations updated their own documents [14] [15] [16] , and other Societies, such as the European Respiratory Society (ERS) 17 , the British Thoracic Society/Association for Respiratory Technology & Physiology (BTS/ARTP) 12 , the Sociedad Uruguaya de Neumologia (SUNEUMO) 18 , the Italian Thoracic Society (ITS/AIPO) 19 , and the Italian Respiratory Society (IRS/SIP) 20 , as well as renowned medical centers such as Cleveland Clinic 21 , recently published statements.

We aim to summarize the available official recommendations on the use of spirometry in the context of COVID-19 infection and to compare them, reviewing in detail the most important aspects, such as eligible patients, health-care workers' and patients' protection, equipment, and environmental management to prevent COVID-19 transmission. These results will help practicing physicians make decisions on how to safely reshape and reopen ambulatory services, tailoring measures to the specific context of their needs, and organizational issues 22 .

We searched and reviewed all recent Guidelines, Consensus documents, Statements, and Position Papers from National and International Societies or local policies of medical centers on how to perform spirometry during COVID-19, published on official websites in four languages: English, Italian, French and Spanish.

To increase the search strategy's sensitivity, we also searched on Google the websites of the spirometer manufacturers using the following terms: COVID-19, Sar-Cov-2, spirometry, pulmonary function test.

We considered the challenging issues related to performing spirometry and the solutions that may be adopted, as suggested by official Recommendations. Table 1 summarizes Societies' Recommendations on performing PFTs.

There was an overall good agreement among Guidelines on limiting PFTs to patients really needed them, weighing the benefits of ongoing care and clinical evaluation with "exposure risk" to COVID-19 for individuals coming to the hospital. Nevertheless, we found heterogeneous indications on the subgroup of patients considered a priority.

The ATS 6 and ERS 17 Recommendations generically advise performance of PFTs when they are essential for immediate treatment decisions of the current illness. At the same time, SPP 16 , SPLF 9 and BTS/ARTP guidelines 12 strongly encourage performing essential procedures only in cancer patients or in cases of pre-operative assessments for urgent surgery. In contrast, the recent update of the Australian Guidelines 14 suggests that asymptomatic patients might undergo PFTs, especially in cases of a pre-operative evaluation for elective surgery. The ITS 11 Guidelines recommend performing PFTs in patients with cystic fibrosis and rapid access lung cancer and in those needing a preoperative assessment for emergency surgery. Furthermore, they recommend spirometry in immunocompromised patients for urgent treatment (e.g. bone marrow transplant, lung transplants, pre-chemotherapy treatments), suggesting testing them first on the day.

Conversely, the Chinese expert Recommendations 5 limit PFTs only to patients needing them; moreover, they specify that in patients with asthma and chronic obstructive J o u r n a l P r e -p r o o f pulmonary disease (COPD), the test might be suspended unless urgently needed for diagnosis and treatment, suggesting the use of a peak flow meter for self-monitoring the lung function. Similar indications come from the Position Paper of the ITS/AIPO Italian Society 19 , which also prioritizes patients needing thoraco-abdominal surgery. The latest released IRS/SIP Recommendations 20 , provide more broad indications, including the diagnosis of COPD and asthma and interstitial lung diseases, the follow-up and the antifibrotic drugs prescription. Cleveland 21 is the only Organization that also mentions patients with pulmonary hypertension, while SUNEUMO 18 also takes into account patients with pneumoconiosis and respiratory drug toxicity. Finally, the SEPAR/AEC/AET/SEAIC 10 Recommendations suggest performing PFTs in negative rooms and postponing them unless urgently needed.

As regards patients recovered from COVID-19 experiencing persistent or evolving respiratory complications, BTS/ARTP 12 Guidelines propose a detailed follow-up: all patients recovered from a severe (hospitalized in Intensive Care Unit/High Dependency Unit, or necessitating protracted dependency on a high fraction of inspired oxygen or noninvasive ventilation during the hospital stay, or discharged with oxygen or with significant ongoing respiratory symptoms) or a mild to moderate pneumonia, or clinically improved patients with persistent changes in the chest X-ray 12 weeks post-discharge, should undergo PFTs.

Patients with a previous COVID-19 pneumonia are also mentioned by the ERS 17

Guidelines that only specify that these patients must not be tested for a minimum of 30 To safely restart PFTs services, it is mandatory to appropriately assess each outpatient, considering everyone as a potential symptomatic or asymptomatic COVID-19, avoiding at the same time denying access to many patients. All Guidelines are generally encouraging similar strategies to guarantee health safety, are implementing measures to warrant social distancing and to identify suspected patients for limiting the transmission of the infection, are ensuring the safety of health-care workers (HCWs) with adequate personal protective equipment (PPEs), because subclinical patients may still transmit the virus.

Chinese 5 , ITS/AIPO 19 , IRS/SIP 20 , and Irish Recommendations particularly emphasize that patients should be scheduled for a visit at a specific date and time, in order to avoid early arrival of the patient and crowded waiting rooms.

The Irish Thoracic Society specifies that patients booked for a visit should wait in their own car, entering the department for testing only after a phone call by the administrative team 11 . No mention of scheduled visits was formulated by ATS 6 , BTS/ARTP 12 , TSANZ/ANZSRS 14 , SSP 8 , SUNEUMO 18 , SPLF 9 , SEPAR/AEC/AET/SEAIC 10 Societies.

The Recommendations generally encourage patients to come to the visit alone, without accompanying persons, when possible, or limited to one caregiver if they need support.

Maintaining a minimum of 2 meters distance between sitting patients is recommended by Irish 11 , Chinese 5 , ITS/AIPO 19 , ERS 17 , and BTS/ARTP 12 Societies, while SEPAR/AEC/AET/SEAIC limit the distance to at least 1 meter. Furthermore, the Chinese task force 5 , and ITS/AIPO 19 Position Paper suggest making a demonstration video focused on the maneuvers for correctly performing spirometry and to project it in the waiting area, enabling patients to be prepared before the visit, while SEPAR/AEC/AET/SEAIC 10 Societies recommend to use educational posters. 

After this screening phase, the patient will perform careful hand hygiene and enter the PFTs operative room; ITS/AIPO 19 Guidelines specify that patients need to wear gloves too.

There is a lack of evidence about whether the PFTs should be considered aerosolgenerating procedures. Nevertheless, HCWs assigned to PFTs lab should adopt all the precautionary measures suggested by WHO, since the procedure needs close contact with the patient and can induce coughing, similar to that induced by collecting diagnostic respiratory samples (e.g. nasopharyngeal swab). All Societies cautiously recommend PPEs use for HCWs performing PFTs, specifying that HCWs should wear filtering facepiece respirators FFP3 or, when not available, FFP2 and eye protection. Only SPLF 9

Guidelines state that HCWs can use a simple surgical mask. Changing disposable gloves between patients is highly recommended and rigorous hand hygiene is essential.

BTS/ARTP 12 Guidelines further specify that HCWs also need to wear a fluid-resistant gown and a disposable plastic apron, while IRS/SIP 20 , SPLF 9 and SEPAR/AEC/AET/SEAIC 10 Guidelines mention only the gown. However, the Chinese task 

Spirometry systems are not designed to be sterile. There are three main potential sources of cross-contamination when performing the test: skin contact, aerosolized particles and saliva/body fluids; therefore, hygiene measures to protect users are crucial.

The ERS 17 , BTS/ARTP 12 , SEPAR/AEC/AET/SEAIC 10 and ITS/AIPO 19 Guidelines specify that in-line bacterial/viral filters should be used to protect the whole circuit from J o u r n a l P r e -p r o o f contamination with exhaled microorganisms, and the patient from inhaling particles from the circuit, while ATS 6 , ITS 11 and TSANZ/ANZSRS 14 Guidelines do not specify any precaution in this regard.

To ensure the protective effect, BTS/ARTP 12 Guidelines recommend using in-line filters with a high-quality filtration performance against viruses but with proven evidence of not altering function measurements. Similarly, ITS/AIPO 19 and the Chinese Task force 5 state that verification of the total resistance of the filter and lung respiratory tube function instrument should be < 1.5 cmH2O at a flow rate of 0-14 L / s · L -1 · s -1 , in order to not affect the results of the lung function test. At the same time, ERS 17 Guidelines suggest selecting a filter with a minimum proven efficiency for a high expiratory flow of 600 to 700 L/min.

Interestingly, only the SPLF 9 Guidelines recommend performing PFTs in a plethysmography boot with a shut door.

As far as bronchodilator challenge is concerned, TSANZ/ANZSRS 14 Societies suggest using the patient's own salbutamol inhaler or a single-use inhaler, while ITS 11 Guidelines recommend considering the use of Turbohaler or an aerosol holding chamber (spacer) device (i.e. aerochamber), the latter also endorsed by the Portuguese Society 16 .

The use of in-line filters does not preclude the necessity for thorough cleaning of the equipment. After each use, equipment cleaning with 75 % ethanol for 3 minutes twice is recommended by the Chinese task force 17 . SEPAR/AEC/AET/SEAIC 10 and BTS/ARTP Guidelines 12 also describe in detail the type of disinfectant solution, as shown in Table 1 .

A general statement regarding regular equipment cleaning protocol following local policies is advised by IRS/SIP 20 .

The use of disposable nose clips is strongly recommended by ERS 17 , BTS/ARTP 12 , ITS/AIPO 19 , IRS/SIP 20 and SEPAR/AEC/AET/SEAIC 10 Guidelines.

Airborne transmission occurs through the dissemination of droplets from infectious patients; the motion of droplets significantly depends on gravity, direction and strength of local airflow, temperature, and relative humidity. It is crucial, therefore, to perform the spirometry in a properly ventilated room, in order to control any possible cross-infection.

Ventilation is defined as the supply/distribution or removal of air from a space by mechanical or natural procedures. The clearance rate of aerosols in a closed space is dependent on the extent of any mechanical or natural ventilation; therefore, the greater the ventilation rate, expressed as the number of air changes per hour (ACH), the sooner any aerosol will be cleared 23 . A single air change is estimated to remove 63% of airborne contaminants: after 5 air changes, less than 1% of airborne contamination is thought to remain 24 . A minimum of 20 minutes, that is 2 air changes, in hospital settings, where most of these procedures occurs, is considered pragmatic 25 .

Nevertheless, the issue of adequate ventilation was considered only by ERS 17 , ITS/AIPO 19 , BTS/ARTP 12 , Chinese task force 5 , SUNEUMO 18 

All the reviewed Guidelines agreed on the importance of cleaning equipment and surfaces; SEPAR/AEC/AET/SEAIC 10 , BTS/ARTP 12 and Chinese 5 Guidelines also recommend the type of cleaning solution to be used, Table 1 .

Disposable cleaning wipes were strongly recommended by SEPAR/AEC/AET/SEAIC 10 BTS/ARTP 12 , ITS 11 , and Cleveland Clinic 21 Guidelines, but only TSANZ/ANZSRS and SEPAR/AEC/AET/SEAIC 10 Guidelines expressly recommend the presence of minimal furnishings that can be easily cleaned and disinfected 14 .

As regards PFTs operating room cleaning, ERS 17 ITS/AIPO 19 and IRS/SIP 20 Guidelines suggest the use of UV light or ozone room decontamination at intervals, compliant with local infection policies, while more detailed precautions are provided by the Chinese task force 5 .

The Chinese task force also recommend switching off the central air conditioner, sanitizing the room at least twice a day, using UV light for at least 30 min a day to clean the air and medical air purification devices for air disinfection during lung function tests.

The suggested time required between visits by ERS 17 , BTS/ARTP 12 Guidelines is 30 min for a regular side room and 60 min for a negative isolation room. The Portuguese Society 16 recommends a period time of 60 minutes between visits and the Nebraska medical center 15 specifies that the operating room must be closed for 1 hour after the visit.

Interesting suggestions come from ITS/AIPO 19 and SPLF 9 Guidelines that recommend a new calibration of the spirometer after the cleaning procedures, and from ERS 17 , the only Society that takes into account high-risk patients, that suggest performing a remote test with live video instructions in these subgroups of patients.

A plan to manage the respiratory issues of people with acute respiratory symptoms, pre-existing chronic lung diseases or conditions that need adequate pulmonary function assessment to be appropriately diagnosed and treated, is essential to prevent an inevitably indirect effect of COVID-19 on frail patients that could be devastating, increasing death and disability.

Manufacturers' policies 26-29 are summarized in Table 2 .

The COVID-19 pandemic completely changed the routine of providing health-care services, shifting from elective to essential/acute management and limiting several diagnostic resources for chronic respiratory patients such as pulmonary function labs and sleep labs 30 . We analyzed Society-specific clinical practice Guidelines on how to safely perform PFTs and the recommendation level of consensus for each clinically relevant problem; we found similarities but also several differences. In particular, the Societies' Guidelines on spirometry during the COVID-19 outbreak differ greatly in relation to the subgroup of patients that need to be prioritized for testing.

The Guidelines agreed about prioritizing patients with urgent need to initiate treatment and pre-operative assessment, except Cleveland 21 , which takes into account also pulmonary hypertension patients, IRS/SIP 20 , which also considered patients with a diagnosis of pulmonary fibrosis and follow-up and for therapy prescription, as well as patients with a 

The review of Guidelines/Recommendations/Position Papers indicate a good agreement in the need to prioritize patients for PFTs, patients screening, HCWs protection, and in the use of in-line filters for spirometry but poor consensus on the subgroup of patients considered a priority, and few indications on the measures to implement for adequate ventilation. We believe that this summary of the available literature may be a useful guide helping HCWs to select appropriate measures, tailored to the highly specific context in which they will be used, to meet the needs of intended users.

Authors' contribution: CC conceived the content, drafted the manuscript and approved the final version to be submitted. PI drafted the manuscript, approved the final version to be submitted. RC, SN, helped in writing the manuscript and approved the final version to be submitted. AS helped in writing the manuscript, revised it critically for important intellectual content and approved the final version to be submitted. NC conceived the content, revised it critically for important intellectual content and approved the final version to be submitted.

Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Competing interests: All authors declare no competing interests. 

Air ventilation and sterilization

Measurements are influenced by the filter's resistance.

Critical preparedness, readiness and response actions for COVID-19: interim guidance. Date last updated: 22

Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering

Chinese Association of Chest Physicians, Pulmonary Function Testing Group, Respiratory Therapeutics Group and Chinese Thoracic Society

Pulmonary Function Laboratories: Advice Regarding COVID-19. 2020. Date last updated

Peak Respiratory Bodies recommend suspension of lung function testing. 2020. Date last updated. Date last accessed

SPLF. Position du groupe Fonction de la SPLF concernant la pratique des Explorations Fonctionnelles Respiratoires pendant la période d'épidémie COVID-19. 2020. Date last updated: 17

Date last accessed

Date last accessed

Date last accessed

SBAR for Performing Pulmonary Function Test in PFT lab

UNMC Nebraska Medicine. Recommendations on Performing Pulmonary Function Test (PFT) in PFT lab. 2020. Date last updated

Recommendation from ERS Group 9.1 (Respiratory function technologists /Scientists) Lung function testing during COVID-19 pandemic and beyond. 2020. Date last updated: 09

Recomendaciones para realizar Estudios Funcionales Respiratorios durante la epidemia causada por el coronavirus SARS-CoV-2 (COVID19). 2020. Date last updated

ITS/AIPO. Le prove di funzionalità respiratoria nell'era della pandemia da COVID-19 -Position Paper. 2020. Date last updated: 9

Esami di funzionalità respiratoria nel contesto COVID-19 Position Paper

Date last accessed

Healthcare Infection Society Working Group on R and Facial P. Guidance on the use of respiratory and facial protection equipment

Date last accessed

Date last accessed

Sleep labs, lung function tests and COVID-19 pandemic -Only emergencies allowed! Pulmonology